ClinicalTrials.govpublic full text
A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis
end stage renal disease, hyperphosphatemia, phosphate binder, dialysis, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 804058
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.